Premenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of premenopausal women with early stage breast cancer and lymphoma
boolean
C0232969 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Premenopausal state | Age | Pregnancy | Menstrual cycle Quantity Timespan
Item
premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant or had at least one menstrual period in the last 12 months
boolean
C0232969 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0025329 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0872291 (UMLS CUI [4,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of postmenopausal women with early stage breast cancer and lymphoma
boolean
C0232970 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Postmenopausal state | Age | Menstruation Absent Duration
Item
postmenopausal women at time of diagnosis > age 50 who have been without period for ≥ 2 years.
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0025344 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0449238 (UMLS CUI [3,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria | Premenopausal state | Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject exclusion criteria for both pre and postmenopausal women with early stage breast cancer and lymphoma
boolean
C0680251 (UMLS CUI [1])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C2986665 (UMLS CUI [4])
C0024299 (UMLS CUI [5])
Secondary Neoplasm Requirement Cytotoxic Chemotherapy
Item
active secondary cancer requiring cytotoxic chemotherapy
boolean
C2939419 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0677881 (UMLS CUI [1,3])
Systemic therapy Malignant Neoplasms
Item
prior systemic treatment for a malignancy
boolean
C1515119 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])